The Kaposi's sarcoma herpesvirus encodes a G-proteincoupled chemokine receptor termed KSHV-GPCR. Expression of this constitutively active GPCR leads to cell transformation and vascular overgrowth characteristic of Kaposi's sarcoma. Previously, we have shown that CXCR2, the closest human homolog, is similarly able to transform cells if continuously stimulated or constitutively activated by amino-acid exchange D138V of the DRY sequence. Here, we demonstrate that STAT3 activation is a prerequisite for transformation in KSHV-GPCR and CXCR2 transfected NIH 3T3 cells. In KSHV-GPCR and D138V transfected cells, STAT-3 is constitutively phosphorylated on Tyr
Introduction
The Kaposi's sarcoma herpesvirus G-protein-coupled receptor (KSHV-GPCR) is the product of open reading frame 74 of the human Herpesvirus 8 (HHV-8). It has been speculated that the KSHV-GPCR has been pirated from its closest homologs, the chemokine receptors CXCR2 or CXCR1 . KSHV-GPCR appears to be involved in the pathogenesis of Kaposi's sarcoma (Offermann, 1996) and primary effusion lymphomas . Expression of KSHV-GPCR stimulates proliferation in rat fibroblasts (Arvanitakis et al., 1997) and causes transformation in NIH 3T3 cells and tumors, when transfected cells are injected into nude mice (Bais et al., 1998) . Furthermore, transgenic mice expressing KSHV-GPCR within hematopoetic cells or endothelial cells develop angioproliferative lesions in multiple organs resembling the Kaposi's sarcoma (Yang et al., 2000; Guo et al., 2003; Montaner et al., 2003) .
The transforming activity of KSHV-GPCR is thought to be a result of its constitutive activation. Although KSHV-GPCR can bind IL-8 and other chemokines, it signals in the absence of ligand via activation of phosphoinositide-specific phospholipase (Arvanitakis et al., 1997) . The same signal transduction cascade is activated by CXCR2 when it binds its ligands IL-8 (CXCL8), GRO-a, and NAP-2. CXCR2 does not exhibit constitutive signaling.
In previous studies we have shown that expression of CXCR2 in NIH 3T3 cells causes transformation as assessed by focus formation and growth in soft agar (Burger et al., 1999) . In addition, NIH 3T3 cells expressing CXCR2 caused tumors and metastases in nude mice (Schraufstatter et al., unpublished results) . This oncogenic behavior of the CXCR2 receptor in the absence of added ligand could be explained by autocrine stimulation by mouse KC, the murine equivalent of gro a. NIH 3T3 cells expressing a point mutation of the CXCR2, which is constitutively activated by amino-acid exchange D138V of the DRY sequence in the second intracellular loop, also transformed transfected NIH 3T3 cells in contrast to another CXCR2 mutant that is poorly G-protein coupled (D138Q-CXCR2) and behaved like untransfected cells (Burger et al., 1999) , indicating that cell transformation is dependent on the signal transduction.
CXCR2 has been described to be expressed on a variety of tumor cells, including breast cancer (Miller et al., 1998) , head and neck cancer (Richards et al., 1997) , melanoma (Norgauer et al., 1996) , pancreatic (Takamori et al., 2000) , and ovarian cancer (Venkatakrishnan et al., 2000) , all cancers with high metastatic index. In addition, recent investigations have shown that activation of the CXCR2 expressed on microvascular endothelial cells is responsible for the angiogenic response to IL-8 (Addison et al., 2000; Schraufstatter et al., 2001) .
The angiogenic (Koch et al., 1992) and growth promoting property of CXC-chemokines (IL-8, gro a, NAP-2, ENA 78 and others) depends on the presence of an ELR sequence in the NH 2 -terminus of the protein (Hebert et al., 1991) . Chemokines that do not express this sequence -or in which this sequence was mutatedare devoid of angiogenic and growth promoting activity (Strieter et al., 1995) . In accordance, the CXCR2 is activated by all ELR containing chemokines in contrast to the CXCR1, which is specific for IL-8 (Lee et al., 1992) .
A feature of many cytokines is that they engage a class of nontyrosine kinase cell surface receptors, which signal to the cell nucleus by activation of the JAK-STAT signaling pathway. STAT (signal transducers and activators of transcription) proteins are latent transcription factors that become activated by phophorylation on a single tyrosine, typically in response to extracellular ligands (Darnell, 1997) . Upon cytokine-induced receptor activation, monomeric cytosolic STATs are thought to be recruited to the cytoplasmic tail of the respective plasma membrane receptor, Tyr-phosphorylated by JAK-family kinases, then they depart the receptor by an unknown mechanism, dimerize, and translocate to the nucleus. In the nuclear compartment PY-STATs bind target DNA motifs and other transcription factors and thus modulate gene expression (Darnell et al., 1994 (Darnell et al., , 1997 Heinrich et al., 1998; Leonard and O'Shea, 1998) .
Ligand-dependent activation of STAT proteins is associated with organ development, cell proliferation, and differentiation, while constitutive activation of STATs often results in growth deregulation (Bromberg, 2002; O'Shea et al., 2002) . Constitutively active STAT3 induces transformation scored by colony growth in softagar and by the ability to form tumors in nude mice. STAT3 protein is constitutively activated in many human cancer cells, and aberrant STAT3 signaling is implicated as an important process in malignant progression deregulation (Bowman et al., 2000; Bromberg, 2002) .
Knowing about the transforming capacity of KSHV-GPCR and CXCR2 and its similarities in signaling together with the transforming capacity of STAT3 signaling which is known to be induced by other cytokine receptors, for example, IL-6 (Heinrich et al., 1998) or chemokine receptors, for example, CXCR4 (Vila-Coro et al., 1999; Soriano et al., 2002) , or CCR2B (Mellado et al., 1998) we were interested whether the JAK-STAT-3 pathway was induced by the KSHV-GPCR and CXCR2, and whether it plays a role in mediating the transforming abilities.
Results

Activation of STAT3 in KSHV-GPCR, CXCR2, and D138V tansfected NIH 3T3 cells and HMECs
Aberrant STAT activation is found in many malignancies, and constitutive activation of STAT3 is associated with cellular transformation. STATs reside latent in the cytoplasm and are activated after tyrosine phosphorylation by Janus kinases (JAKs) associated with cytokine receptors (Faruqi et al., 2001) . Active STATs dimerize and translocate to the nucleus. We examined whether the previously described constitutive activation of the KSHV-GPCR and the CXCR2 mutant D138V also affects STAT3 signaling. As shown in Figure 1a nuclear extracts of KSHV-GPCR transfected cells showed constitutive STAT3 phosphorylation at Tyr705 after overnight serum starvation, which could not further be increased by IL-8 or gro a stimulation. Stimulation with IP-10, an inverse agonist of the KSHV-GPCR, did not have any influence on STAT3 phosphorylation. The D138V mutant also showed constitutive phosphorylation of STAT3 (Figure 1b) . In contrast, the wild-type CXCR2 showed very weak constitutive STAT3 phosphorylation, which could be activated by IL-8 stimulation. Maximum STAT3 phosphorylation was seen after 10-30 min. After 60 min the STAT3 phosphorylation (Figure 1d ). In contrast, untransfected or NIH 3T3 cells stably transfected with CXCR1 did not show any STAT3 phosphorylation at all (Figure 1e and f). Total STAT3 levels were also blotted on the nuclear extracts of all transfectants and were not influenced by the stimulation of the cells (lower lanes as indicated). Since we were not able to detect JAK2 phosphorylation we blotted the cytosolic fraction with a JAK2 specific antibody. In accordance with the STAT3 activation JAK2 was detectable in KSHV-GPCR without any stimulation ( Figure 1a ) and in CXCR2 upon stimulation with IL-8 after 10-30 min (Figure 1d ).
Human microvascular endothelial cells (HMECs) are known to express CXCR2. We examined whether signaling in HMECs would also lead to STAT3 phosphorylation upon IL-8 stimulation. The cells were serum-starved overnight and nuclear extracts were subjected to Western blot analysis. HMECs showed no constitutive STAT3 phosphorylation but STAT3 phosphorylation could be induced by IL-8 stimulation after 10 min. After 60 min, phosphorylation was still at a high level ( Figure 1c ). In accordance with the STAT3 phosphorylation JAK2 was also detectable in the cytosolic fractions after 10 min IL-8 stimulation.
Inhibition of STAT3 phosphorylation by AG490
Tyrphostin AG490 is described as a specific JAK2 kinase inhibitor. Since cytokine-induced receptor activation can lead to the recruitment of monomeric cytosolic STATs to the cytoplasmic tail of the respective plasma membrane receptor and Tyr-phosphorylation by JAKfamily kinases, we investigated whether STAT3 phosphorylation could be inhibited by AG490. Figure 2 shows STAT3 phosphorylation in nuclear extracts of NIH 3T3 cells stably expressing KSHV-GPCR (a), D138V (b), and wild-type CXCR2 (c). In all cases, STAT3 phosphorylation could be almost completely inhibited by AG490, which indicated that STAT3 phosphorylation depends on JAK2 activation. In contrast, none of the other tested inhibitors, AG1478 to inhibit the previously described EGFR transactivation, PP2 to inhibit the src kinase, toxin B to inhibit Rho GTPases, Y27632 to inhibit the Rho kinase (ROCK), or Pertussis toxin inhibited STAT3 phosphorylation (data not shown).
JAK2 and Rho GTPases are required for stress fiber formation in CXCR2, KSHV-GPCR, and D138V transfected NIH 3T3 cells Cytoskeletal reorganization is a prerequisite for migration of cells. Actin polymerization can easily be visualized with phalloidin fluorophores. Thus, F-actin formation was used to investigate whether the JAK-STAT pathway is involved in cytoskeletal reorganization processes. We performed studies on stress fiber formation in stably transfected NIH 3T3 cells expressing CXCR2, KSHV-GPCR, and D138V. Under normal culture conditions with 10% calf serum (CS), all three transfectants show prominent stress fiber formation (Figure 3a , f, and j). After 16 h serum starvation, CXCR2 transfected NIH 3T3 cells revealed a disassembled cytoskeleton ( Figure 3b ). As we know from previous studies, CXCR2 displays in contrast to CXCR1 a prolonged increase in F-actin with a maximum between 5 and 30 min after stimulation (Schraufstatter et al., 2003) . In this study, cells were stimulated with 200 ng/ml IL-8 for 10 min and stress fibers were detected by fluorescence microscopy. Stress fiber formation could clearly be induced after IL-8 stimulation in CXCR2 transfected cells (Figure 3c ). In contrast, the D138V mutant and KSHV-GPCR transfected cells did not show any disassembling of the cytoskeleton, even after 24-h serum starvation ( Figure  3g and k). Treatment with AG490 led to disorganization of stress fibers in either case (Figure 3d , h, and l). Stress fiber formation was also inhibited by pretreatment of 
AG490 inhibits haptotaxis in CXCR2 transfected NIH 3T3 cells
To determine the influence of the JAK2-STAT3 signaling on chemotaxis of CXCR2, migration of transfected NIH 3T3 cells to an IL-8 gradient was tested. Migration of the CXCR2 transfectants in a coated membrane was significantly enhanced (about two-fold) by IL-8 stimulation (Figure 4) . We next examined the inhibitory effect of AG490 in haptotaxis assays using CXCR2 transfected NIH 3T3 cells stimulated with 200 ng/ml IL-8. As expected, AG490 blocked the IL-8 induced cell migration almost completely (Figure 4) . DMSO was used as a control to rule out inhibitory effects of the solvent of AG490. The same experiments were carried out with KSHV-GPCR and D138V transfected NIH 3T3 cells, but since there is no migration induced by the ligands IL-8 or gro a, there was no influence of AG490 or the inverse agonist IP-10 detectable.
AG490 inhibits tube formation/angiogenesis in HMEC and tube formation/proliferation in Matrigel in transfected NIH 3T3 cells
Since cell migration is a prerequisite for the sprouting of vessels during angiogenesis, the effect of AG490 was also determined in an in vitro angiogenesis assay, in which the capillary-like structures in a collagen gel is determined (Korff and Augustin, 1999) . As previously shown (Schraufstatter et al., 2001) Next, we tried to test for branching/sprouting in transfected NIH 3T3 cells. It has been described before that maligne transformed NIH 3T3 are also able to form tube structures (Van Rompaey et al., 2002) by which aggressive tumor cells generate nonendothelial cell-lined channels delimited by extracellular matrix. As shown in Figure 6a , untransfected NIH 3T3 show only little sprouting, whereas KSHV-GPCR (Figure 6b ), D138V (Figure 6e ), and to a lesser extend CXCR2 wildtype (Figure 6g ) transfected NIH 3T3 cells do show significant sprouting in Matrigel. The sprouting into Matrigel, which requires migratory and invasive growth processes, can be inhibited impressively by adding AG490 (Figure 6d , f, and h).
AG490 inhibits focus formation in CXCR2 and KSHV-GPCR transfected NIH 3T3 cells
Constitutive STAT3 activation is known to lead to cell transformation. To verify whether the previously reported transforming capacity of CXCR2 or KSHV-GPCR in NIH 3T3 cells (Burger et al., 1999) was dependent on the JAK2-STAT3 pathway, we tested for focus formation. The JAK2 inhibitor Tyrphostin AG490 was added to the focus formation assays every 2 days for a period of 2-3 weeks. When treated with AG490 the focus formation seen in untreated controls was completely inhibited (Figure 7) . DMSO served as a control to rule out unspecific inhibition of focus formation by the solvent of AG490.
Discussion
In our previous study we have shown that CXCR2 is able to transform NIH 3T3 cells when continuously Cells were photographed after 48 h outgrowth of tube like structures stimulated or constitutively activated by a mutation in the highly conserved DRY sequence in the second intracellular loop (D138V). In contrast, CXCR1 did not show any transforming capacity, even if mutated the same way in the DRY sequence or continuously stimulated. These similarities in signaling of KSHV-GPCR and CXCR2 in contrast to CXCR1 led us to the question, which step in the signal transduction cascade would be critical for the transforming events. Looking for STAT3 phosphorylation we found that KSHV-GPCR and the constitutively activated CXCR2 mutant D138V showed constitutive STAT3 phosphorylation on Tyr705. In accordance with our previous observations CXCR2 wild type did not show significant STAT3 phosphorylation, but could be activated upon IL-8 stimulation. In contrast, stimulation of the CXCR1 with IL-8 did not lead to STAT3 phosphorylation, thus the STAT signaling seems to be a significant difference between these two so closely related chemokine receptors. Inhibition of the JAK2-STAT3 pathway in transfected NIH 3T3 cells or HMECs by AG490 led to significant impairment of typical processes involved in tumor growth and angiogenesis like stress fiber formation, migration, sprouting into matrigel, and focus formation.
STATs are latent transcription factors that mediate cytokine and growth factor directed transcription. Aberrant activation of STAT proteins is often associated with cellular transformation by various oncoproteins. During the multistep process of tumorigenesis, cells lose their normal ability to regulate cell cycle progression and apoptosis, and acquire abnormal patterns of growth factor signaling, angiogenesis, and invasive growth. STATs contribute to tumorigenesis through their intimate connection to growth factor signaling, apoptosis, and angiogenesis (Bromberg, 2002) . Constitutively activated STATs are detected in a wide variety of human cancer cells, including breast, prostate, renal cell, melanoma, ovarian, lung, leukemia, lymphoma, multiple myeloma, and pancreatic cancer cells (Bowman et al., 2000; Scholz et al., 2003) . In cell culture, active STAT3 is either required for transformation, enhances transformation induced by other events, or blocks apoptosis (Bromberg et al., 1999) .
There are no reports on STAT3 activation through the CXCR2 or the KSHV-GPCR so far. Recently, constitutively activated STAT3 has been described by Aoki et al. (2003) in primary effusion lymphoma (PEL). PEL represents a lymphomatous effusion in body cavities, and most cases exhibit infection with KSHV Nador et al., 1996) . STAT3 is constitutively phosphorylated in PEL cell lines and transduction of dominant-negative STAT-3 and pharmacological STAT3 inhibition caused caspase-dependent cell death. These findings suggest that activated STAT3 signaling directly contributes to malignant progression of PEL by preventing apoptosis, acting through the prosurvival protein survivin. This report fits very well with our results of constitutive STAT3 activation in KSHV-GPCR transfected NIH 3T3 cells, although Aoki et al did not relate the constitutive STAT3 activation to KSHV-GPCR expression or signaling. However, they were able to induce apoptosis in PEL cell lines by inhibiting STAT3 signaling either by transfection of a dominant-negative STAT3 construct or by treatment with the JAK2 inhibitor AG490.
Expression of KSHV-GPCR in vivo is restricted to a few tumors, mainly KSHV and PEL. In contrast, CXCR2 expression has been described in a variety of frequently occurring cancers, for example, breast cancer, 5 untransfected cells and cell foci were stained with crystal violet after 2 weeks in culture and photographed. A concentration of 50 mM AG490 or the same amount of DMSO as vehicle was added every other day. Untransfected NIH 3T3 cells without addition of transfectants were grown as a control melanoma, ovarian cancer, pancreatic cancer, and prostate cancer. Cells transfected with CXCR2 or KSHV-GPCR have been described to secrete higher levels of IL-8 (Shepard et al., 2001; Schraufstatter et al., 2003) . Thus in tumors, which express CXCR2, the cascade from ELR chemokine activation to increased IL-8/gro a production may serve as an autocrine loop leading to continuous STAT3 activation that augments the motility and anchorage independent growth of the cancer cells. This appears particularly relevant, since the expression of high levels of IL-8 family chemokines have been associated with poor outcome in a variety of human cancers (Greene et al., 1997; Bellocq et al., 1998) .
The mechanism on JAK2-STAT3 activation by chemokine receptors is not fully understood. There are observations that chemokine receptors are tyrosine phosphorylated and several members of the JAK family associate with activated receptors independent of the association of Gi . For example, following binding of CCL2 to CCR2, the Y139 residue in the conserved chemokine receptor DRYLAIF motif is probably the primary target for JAK2-mediated phosphorylation of the CCR2 receptor. Mutations of this tyrosine to a phenylalanine (CCR2bY139F) results in a 'dead' receptor that is unable to recruit or activate JAK2, thus impairing the activation of Gi . These results fit very well with our previous observation, that mutation of the DRY sequence of the CXCR2 is critical for the activity of this receptor. Mutation of the DRY sequence to D138Q did not lead to cell transformation, whereas the D138V mutation does lead to constitutive activation and cell transformation (Burger et al., 1999) . We were not able to block the STAT3 phosphorylation in CXCR2 transfected NIH 3T3 cells by Pertussis toxin (data not shown), which suggests that JAK associates directly with the receptor independently of Gia proteins. Recently, Wong et al. (2001) also described for the CCR5 that Jak2 was directly phosphorylated by receptor activation through RANTES independent of Gia proteins. The question whether Rho GTPases are involved in STAT3 activation is still unclear or may be distinct among different GPCR. For example, Pelletier et al. (2003) could show that STAT transcriptional activity was Rac-dependent, whereas our first results using Toxin B for the inhibition of all Rho family proteins did not show any decrease in STAT3 phosphorylation. Our future work will investigate in more detail whether the Rho GTPases might play a role in the STAT3 signaling of CXCR2 and KSHV-GPCR. In our previous work we demonstrated that the CXCR2 transactivates the EGFR and blockade of EGFR transactivation by AG1478, an inhibitor of the tyrosine kinase activity of the EGFR, led to the inhibition of migratory responses in endothelial cells (Schraufstatter et al., 2003) . As Shao et al. (2003) and others described that the EGFR activation can also lead to STAT3 phosphorylation, we tested whether AG1478 would inhibit the STAT3 phosphorylation in our transfected NIH 3T3 cells (data not shown). However, there was no influence on STAT3 phosphorylation, which indicates that the EGFR transactivation in CXCR2 transfectants seem to occur downstream of the JAK2-STAT3 activation.
IL-8 mediates cell migration in endothelial cells and NIH 3T3 cells in a CXCR2-dependent manner. This contrasts with the situation in neutrophils and other leukocytes, where chemotaxis is primarily mediated by the CXCR1. It therefore appears that chemotaxis is not determined simply by the receptor sequence, but depends on the specific downstream effector interplay that differs in different cell types. We could show that CXCR2 dependent actin polymerization and migration in NIH 3T3 cells is dependent on JAK2-STAT3 signaling. This is not the typical chemotactic signaling described so far. However, there is a recent report of Soriano et al. (2003) on CXCR4 that describes a dependence of chemotaxis on the JAK2-STAT3 pathway that is implicated in converting stationary epithelial cells into migratory cells. Chemokine mediated cell activation thus appears to include several sequential steps. Probably, ligand binding induces receptor dimerization leading to conformational changes and exposing the usually hidden tyrosine residue in the DRY motif to the cytoplasm (Bockaert and Pin, 1999 ) that permits JAK access to the receptor. This JAK association with the receptor seems to be critical for chemotactic responses, as Soriano et al. (2003) could show that chemotactic responses were completely abolished in JAK2 deficient cell. Inhibition of JAK2 kinase by AG490 in our migration experiments with CXCR2 transfected NIH 3T3 cells also abolished the migratory response of IL-8 stimulation. Therefore, we suppose that the migratory response through CXCR2 activation in HMEC or NIH 3T3 cells uses the same signaling events.
The mutation in the DRY motif in our CXCR2 mutant or the KSHV-GPCR also leads to constitutive STAT3 phosphorylation, which we could inhibit by AG490. Supposedly, the constitutive STAT3 phosphorylation in the D138V mutant and the KSHV-GPCR is also dependent on the JAK2 association with the receptor due to the changed conformation. The connection of chemokine receptor activation with the JAK2-STAT3 signaling might explain the transforming capacity of the CXCR2 and the KSHV-GPCR since the STAT3 signaling cascade is already well known for its oncogenic influence. The fact that we are able to inhibit angiogenetic responses in HMECs in vitro and tube formation in transfected NIH 3T3 cells as well as focus formation by the JAK2 inhibitor AG490 leads to the conclusion that the JAK2-STAT3 pathway plays a critical role in the CXCR2 and KSHV-GPCR induced cell transformation and angiogenesis.
In summary, our results indicate that activation of CXCR2 and constitutive activation of the KSHV-GPCR causes JAK2-dependent STAT3 activation. This signaling cascade might play a critical role in KSHV-GPCR induced cell transformation, in an autocrine manner in angiogenesis, and for proliferation and transformation of cancer cells that express CXCR2. In addition, it may also function in a paracrine manner by high levels of cytokines of the IL-8 family in the tumor environment. Thus, this study provides important information on chemokine induced signaling that regulates malign cell motility and proliferation. Inhibition of these pathways seems to be feasible and might lead to new therapeutic avenues for CXCR2 and KSHV-GPCR expressing tumors.
Materials and methods
DNA constructs, transfection, and cell culture
The CXCR2, D138V-CXCR2, and KSHV-GPCR constructs have been described previously (Burger et al., 1999) . NIH 3T3 mouse fibroblasts were grown in DMEM containing 10% CS and transfected with CXCR2, D138V-CXCR2, and KSHV-GPCR by the calcium phosphate precipitation technique (Wigler et al., 1978) , followed by a 3-min glycerol shock after 5 h. Stable cell lines were selected with 600 mg/ml of G418.
Immortalized dermal microvascular endothelial cells (HMECs) were grown in EGM (endothelial cell growth medium, Clonetics, San Diego, CA, USA). IL-8 was purchased from R&D Systems, Wiesbaden, Germany. For inhibitor studies cells were preincubated for 30 min with 50 mM AG490, or Y27632 (Biomol, Plymouth Meeting, PA, USA).
F-actin response in HMECs and NIH 3T3 cells
Polymerized actin was visualized as previously described (Schraufstatter et al., 2001) . Briefly, NIH 3T3 cells stably transfected with CXCR2, D138V, or KSHV-GPCR were seeded at low density on coverslips and grown in DMEM containing 10% CS. CXCR2 transfected cells were serum starved for 16-18 h, D138V, and KSHV-GPCR for 24 h, and stimulated with 200 ng/ml IL-8 for 10 min or left unstimulated respectively. Some of the cells were incubated with inhibitors AG490 (50 mM), or Y27632 (10 mM) for 30 min prior to the stimulation with IL-8. All experiments were performed at 371C in a tissue culture incubator. For F-actin localization, cells were fixed for 20 min in 3% paraformaldehyde in PBS, permeabilized for 5 min in 0.2% Triton X-100, incubated with 25 mU/ml of Alexa 488-phalloidin (Molecular Probes, Eugene, OR, USA) for 30 min, washed three times with PBS and mounted with Antifade (Molecular Probes). Fluorescence microscopy was performed on a Zeiss Axiovision 2.0 microscope with the axioplan 2.0 software to obtain digital images.
Cell migration assay
The bottom side of Transwell filters (Corning Costar, Acton, MA, USA) was coated with 230 ml bovine collagen (100 mg/ml, Cohesive Technologies, Franklin, MA, USA) in PBS and blocked with 1% bovine serum albumin (BSA, Sigma). To determine cell migration in CXCR2 transfected NIH 3T3 cells, DMEM containing 10% CS and 200 ng/ml IL-8 was pipetted into the bottom well and 1 Â 10 5 CXCR2 transfected NIH 3T3 cells in the same media were added to 8 mm pore size inserts. For inhibition studies, the cells were preincubated for 30 min with 50 mM AG490 or the same amount of DMSO as a control. The cells were incubated in a tissue culture incubator for 48 h at 371 (Sells et al., 1999) . After that time, cells in the upper well were carefully removed with a cotton swab and transmigrated cells were stained for 10 min with 0.09% crystal violet and counted microscopically. Results are means7s.e.m. of four to six experiments in duplicate.
Western blotting
Cells were grown to confluence on 100-mm tissue culture plates, serum-starved for 24 h, stimulated with 200 ng/ml IL-8 for the indicated times at 371, washed with ice-cold PBS and lysed in 400 ml lysis buffer (150 mM NaCl, 25 mM TRIS, pH 7.5, 1 mM EDTA, 2 mM sodium vanadate, 10 mM NaF, 2 mM sodium pyrophosphate, 1% Nonidet P40, 2 mg/ml aprotinine, 2 mg/ml leupeptin, 2 mM PMSF, 10% glycerol). Nuclear extracts were prepared as described (Zinck et al., 1993; Muller et al., 2000) . The resulting pellets were suspended in 30 ml SDS sample buffer, boiled for 3 min, and loaded onto 10% SDS polyacrylamide gels. Western transfers and blots were performed according to the standard protocols. Antibodies for STAT3, pTyr705-STAT3 were from Cell Signalling Technology, Inc. Beverly, MA, USA, and JAK2 from Upstate Biotechnology, Lake Placid, NY, USA. Immunoreactive bands were visualized using horseradish peroxidase-conjugated goat-anti-rabbit secondary antibody and the enhanced chemiluminescence system (Amersham Biosciences, Freiburg, Germany).
Generation of cell spheroids and sprouting assay
Endothelial cell spheroids of defined monolayers of HMECs were generated as described (Korff and Augustin, 1999) . In brief, confluent monolayers of HMECs were trypsinized. Cells were suspended in corresponding culture medium containing 20% methocel, seeded into nonadhesive round-bottom 96-well plates (Greiner, Frickenhausen, Germany) . Under these conditions, all suspended cells contribute to the formation of a single spheroid per well of defined size and cell number (750-1000 cells/spheroid). The methocel used for these experiments was diluted from a stock solution that was generated by dissolving 6 g of carboxymethylcellulose (Sigma) in 500 ml medium (EGM, Clonetics). The spheroids were harvested within 24 h, centrifuged at 300-500 g, and embedded into collagen gels. A collagen stock was prepared prior to use by mixing 8 vol acidic rat tail collagen type I (Upstate Biotechnology, equilibrated to 2 mg/ml at 41C) with 1 vol 10 Â HBSS (Gibco BRL) and 1 vol 0.2 N NaOH to adjust the pH to 7.4. This stock solution (0.5 ml) was mixed with 0.5 ml room temperature medium (EBM basal medium, Clonetics) with 2% FCS containing 0.5% (w/v) carboxymethylcellulose to prevent sedimentation of spheroids prior to polymerization of the collagen gel. The spheroid containing gel was rapidly transferred into 24-well plates and allowed to polymerize for at least 30 min. EBM basal medium (0.1 ml) containing stimulants and inhibitors was pipetted on top of the gel. The gels were incubated in a 371 tissue culture incubator and sprouting of the cells was photographed at 48 h. The same method was applied to the NIH 3T3 cells transfected with CXCR2, D138V, and KSHV-GPCR, instead of EBM, DMEM was used as medium.
Focus formation assay
For the focus formation assay, 200 stably transfected NIH 3T3 cells were seeded on a layer of 10 5 untransfected cells, as described (Burger et al., 1999) and cell foci were counted after 2 weeks in culture. A concentration of 50 mM AG490 or the same amount of DMSO as vehicle was added every other day.
